Pinned Tweet
A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies: Stem Cell Reports cell.com/stem-cell-reports/f…
Celeste Karch retweeted
Out now. A collaboration with Sofia Lövestam, Masato Hasegawa and Sjors Scheres. We report that tau filaments extracted from the brains of individuals with Alzheimer’s disease and corticobasal degeneration breed true in the brains of wild-type mice. nature.com/articles/s41586-0…
Celeste Karch retweeted
Blood vessels in the brain deteriorate in Alzheimer’s, especially in APOE4 carriers. But what drives this damage?
Our new study, out now in @CellPressNews , uncovers a mechanism linking APOE4 to vascular fibrosis and amyloid accumulation in the brain. 🧠🧬
Celeste Karch retweeted
New TYP lab paper out today in @PNASNews from former PhD student Zach Augur and postdoc @FogoGarrett all about how astrocytic BAG3 coordinates Alzheimer's proteostasis proteins! Read all about it here: pnas.org/doi/10.1073/pnas.25…
Celeste Karch retweeted
Thrilled to see PsychAD published! đź§
A journey begun in 2019: 60+ investigators, 8 institutions, 1,494 human brains—illuminating brain aging and disease.
Supported by NIA. Made possible by the generosity of donors and families.
psych-ad.org/
nature.com/collections/jfibi…
Celeste Karch retweeted
One unsolicited piece of advice for new #gradstudents. Don't settle on ALL of your #rotations before school starts. Use the first semester to explore. Talk to people! Check out labs and areas that you haven't considered! Go outside of your comfort zone! Let yourself be surprised!
Celeste Karch retweeted
The FDA has cleared a blood test developed from technology invented at WashU Medicine to aid in diagnosing Alzheimer’s disease. The test, PrecivityAD2, can detect amyloid plaque biomarkers with over 90% accuracy.
medicine.washu.edu/news/fda-…
Celeste Karch retweeted
APOE genotypes differentially remodel the astrocytic lipid droplet proteome to shape lipid droplet dynamics: nature.com/articles/s41467-0…
Celeste Karch retweeted
MAPT splicing modulators reduce 4R tau and rescue tauopathy phenotypes in human neurons and in a mouse model | Science Translational Medicine science.org/doi/10.1126/scit…
Celeste Karch retweeted
Happy to share the lab's new work characterizing the impact of a youth-associated protein on microglial function. Congrats to 1st author Brittany Hemmer, w/ excellent contributions f/ @philippi_sarah and all co-authors!
@IcahnMountSinai
@SinaiBrain
Paper: nature.com/articles/s41467-0…
Celeste Karch retweeted
Huge faculty recruitment effort at the University of Chicago -- a division-wide, open-rank search looking to hire about 20 faculty across 5 research areas in biology. Come be our colleague!
Full announcement: uchicago.app.box.com/s/ckih9…
Celeste Karch retweeted
Very excited to announce ENCODE GRAMMAR (Genomic Regulatory Atlas of sequence Models, Motifs, Annotations & Rules): 3,865 experiment-specific deep learning model sets and sequence annotations for decoding human regulatory DNA. 1/
Celeste Karch retweeted
Excited to see our work now published science.org/doi/10.1126/scie…!
Lysosomal dysfunction has long been considered a hallmark of aging, but we still know remarkably little about what actually changes inside lysosomes as organisms grow old. Using rapid lysosome isolation and metabolomics, we built the first atlas of lysosomal aging across tissues.
Celeste Karch retweeted
How do lipids influence aging?
We find that membrane lipid composition impacts neural stem cell aging and 'rejuvenation'!
HUGE congratulations to @xiaoaizh on her paper just published at @ScienceAdvances!! 🤩🍾
And a big thank you to all our collaborators!
A thread đź§µ...
Celeste Karch retweeted
I'm excited to announce that our study, Transcriptional regulation of disease-relevant microglial activation programs, has been published this morning in Neuron: cell.com/neuron/fulltext/S08…. We discovered functional regulators of six microglia activation states!
Celeste Karch retweeted
New pre-print from us! We compare two iPSC-microglia protocols, and take a look at the cell autonomous and non-cell autonomous effects of MAPT mutation:
biorxiv.org/content/10.64898…
Celeste Karch retweeted
TDP-43 subtypes shape transcriptomic signatures in Alzheimer's disease biorxiv.org/content/10.64898…
@PrudencioLab
Excited to share our new transcryptomics study in AD where we use quantiative measures of pathological pTDP-43 and pTau to discern changes resulting from each pathology.
Celeste Karch retweeted
Studying these young Alzheimer's patients led to breakthroughs, but the funding was cut.
npr.org/2026/05/07/nx-s1-575…
Celeste Karch retweeted
We are excited to announce that Dr. Ana Maria Cuervo @AMCuervoLab will be our next ISMND webinar speaker!
Selective #autophagy: fighting #neurodegeneration one protein at a time
May 14, 2026
10-11am (ET)
Host: Dr. Hui Zheng
Registration: bit.ly/4tXtGzN
Celeste Karch retweeted
🚨 New in Sci Transl Med! science.org/doi/10.1126/scit…
Our cross‑fluid proteogenomic study shows <30% of pQTLs are shared between CSF and plasma, revealing why plasma misses key biology. We identify 427 protein–trait (249 new) links. Context matters for target discovery. 🧠🔬
New collaborative study in Nature Medicine! Our AcTau174 antibody powers a sensitive CSF assay from Teunissen lab that cleanly separates FTLD-TDP from FTLD-Tau & tracks cognitive decline in AD & FTLD—enabling subtype-specific clinical trial enrollment nature.com/articles/s41591-0…




























